Where does Tangen Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tangen Biosciences, Inc. ranks #43,501 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tangen Biosciences, Inc. hold?

Tangen Biosciences, Inc. holds 6 US utility patents granted between 2019 and 2023, spanning 6 technology areas.

What is Tangen Biosciences, Inc.'s Innovation Score?

Tangen Biosciences, Inc. has an Innovation Score of 29.1 out of 100 (30th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Tangen Biosciences, Inc. focus on?

Tangen Biosciences, Inc.'s top technology area is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE) with 6 patents, ranking #336 of 1,325 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Tangen Biosciences, Inc.'s patent grant rate increasing or decreasing?

Tangen Biosciences, Inc.'s recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Tangen Biosciences, Inc.'s patents?

Tangen Biosciences, Inc.'s patents average 20.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Tangen Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Tangen Biosciences, Inc.

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tangen ranks #43,501 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#43,501
of 49,997 US assignees by volume: 30th percentile
by Innovation Score (29.1/100): 20.7
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R43501 · US Corporation #43,501 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #43,501/49,997
PHOTO-FINISH Taminco BV
CPC-NARROW B01L · 6 areas
INNOV-THIN 29.1/100
CLAIMS-DENSE 20.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Taminco BV (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tangen’s 29.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (23%) Velocity 1.3 pts (4%) Breadth 8.7 pts (30%) Claim depth 12.4 pts (43%)

Qualcomm Incorporated · highest

85
Cascade Maverik… · near

29
CLEAN IO · near

29
Touchtype · near

29
Alfa Laval Olmi S P A · near

29
Tangen Biosciences · this assignee

29
3D Lighting… · lowest

7

What this shows Tangen's Innovation Score is 29.1/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Tangen?

Each dot is one of Tangen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tangen’s own 20.7 claims/patent is ABOVE the 11.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Tangen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tangen's grants concentrate

Tangen Biosciences, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2019. By volume, Tangen sits between Taminco BV and Tankbots, Inc..

Tangen's three-year grant acceleration

Tangen Biosciences, Inc. shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Taminco BV

6
Tampro

6
TAN DE Tech

6
Tang Yang Dies

6
Tangentix

6
Tangi0

6
Taniobis

6
Tankbots

6
Tangen Biosciences ◀

6

What this shows Tangen holds 6 patents at rank #43,464, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tangen

By rank, the assignees closest to #43,464 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Tangen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Tangen, neither rank-band nor same-CPC leaders (those blocks stay above). In B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), Tangen ranks #336 of 1,325 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (29 here).

Alfa Laval Olmi S.P.A. 29 CLEAN.IO, Inc. 29 Touchtype Limited 29 Cascade Maverik Lacrosse, LLC 29

Tangen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 30th percentile higher than 30% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Tangen Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	16.7%
2020	2	33.3%
2021	2	33.3%
2023	1	16.7%

Which technologies does Tangen Biosciences, Inc. patent most?

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Tangen Biosciences, Inc.'s patent record in context - here's where to go next.

Tangen Biosciences, Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 100% of its portfolio - see every assignee active in that class. Explore B01L
Ranked #43,501 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Tangen Biosciences, Inc. against Taminco BV, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.